General introduction
Historical background
Classification of hepatitis C antiviral drugs
Clinical disorders associated with Hepatitis C
Dipeptidylpeptidase-4 inhibitors (DPP-4 inhibitors)
Physicochemical properties of the investigated drugs
Pharmacokinetics of the investigated drugs
Analytical review
Official methods of analysis
Reported methods of analysis
Scope of investigation
Part I chromatographic methods
Section A High performance liquid chromatographic methods
Chapter 1 HPLC method for simultaneous determination of sofosbuvir and daclatasvir
Chapter 2 HPLC method for simultaneous determination of sofosbuvirledipasvir binary mixture
Section B Spectrodensitometric methods
Chapter 1 TLC- spectrodensitometric method for simultaneous
Chapter 2 HPTLC- spectrodensitometric method for simultaneous determination of sofosbuvir-ledipasvir binary mixture
Chapter 3 HPTLC- spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir
Part II Spectrofluorimetric methods
Chapter 1 Ultrasensitive spectrofluorimetric method for rapid determination of daclatasvir and ledipasvir in human plasma and pharmaceutical formulations
Chapter 2 New and sensitive spectrofluorimetric determination of saxagliptin in tablets and human plasma via derivatization with o-phthalaldehyde
General conclusion
References
Summary
Publications & conference contributions
Arabic Summary
الفهرس 
